Cargando…

Cytomegalovirus Viremia as a Risk Factor for Mortality Prior to Antiretroviral Therapy among HIV-Infected Gold Miners in South Africa

BACKGROUND: Cytomegalovirus (CMV) viremia has been shown to be an independent risk factor for increased mortality among HIV-infected individuals in the developing world. While CMV infection is nearly ubiquitous in resource-poor settings, few data are available on the role of subclinical CMV reactiva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fielding, Katherine, Koba, Ai, Grant, Alison D., Charalambous, Salome, Day, John, Spak, Cedric, Wald, Anna, Huang, Meei-Li, Corey, Lawrence, Churchyard, Gavin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3192109/ https://www.ncbi.nlm.nih.gov/pubmed/22022413 http://dx.doi.org/10.1371/journal.pone.0025571

Ejemplares similares

Comparing QuantiFERON-TB Gold Plus with QuantiFERON-TB Gold in-tube for diagnosis of latent tuberculosis infection among highly TB exposed gold miners in South Africa
por: Ntshiqa, Thobani, et al.
Publicado: (2022)

Viral Suppression Following Switch to Second-line Antiretroviral Therapy: Associations With Nucleoside Reverse Transcriptase Inhibitor Resistance and Subtherapeutic Drug Concentrations Prior to Switch
por: Johnston, Victoria, et al.
Publicado: (2014)

Second-Line Antiretroviral Therapy in a Workplace and Community-Based Treatment Programme in South Africa: Determinants of Virological Outcome
por: Johnston, Victoria, et al.
Publicado: (2012)

Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study
por: Russell, Elizabeth C, et al.
Publicado: (2010)

Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study
por: Dahab, Mison, et al.
Publicado: (2010)

Predictors of silicosis and variation in prevalence across mines among employed gold miners in South Africa
por: Knight, Dave, et al.
Publicado: (2020)

Risk factors for poor virological outcome at 12 months in a workplace-based antiretroviral therapy programme in South Africa: A cohort study
por: Fielding, Katherine L, et al.
Publicado: (2008)

Cytomegalovirus Viremia, Pneumonitis, and Tocilizumab Therapy
por: van Duin, David, et al.
Publicado: (2011)

Trends in silicosis prevalence and the healthy worker effect among gold miners in South Africa: a prevalence study with follow up of employment status
por: Knight, David, et al.
Publicado: (2015)

Incidence of HIV-Associated Tuberculosis among Individuals Taking Combination Antiretroviral Therapy: A Systematic Review and Meta-Analysis
por: Kufa, Tendesayi, et al.
Publicado: (2014)

Comparison of Tenofovir, Zidovudine, or Stavudine as Part of First-Line Antiretroviral Therapy in a Resource-Limited-Setting: A Cohort Study
por: Velen, Kavindhran, et al.
Publicado: (2013)

Anakinra/steroids: Cytomegalovirus viremia: case report
Publicado: (2022)

Evaluation of a point-of-care tuberculosis test-and-treat algorithm on early mortality in people with HIV accessing antiretroviral therapy (TB Fast Track study): study protocol for a cluster randomised controlled trial
por: Fielding, Katherine L, et al.
Publicado: (2015)

Cytomegalovirus Viremia Predicts Postdischarge Mortality in Kenyan HIV-Exposed Uninfected Children( )
por: Pavlinac, Patricia B, et al.
Publicado: (2022)

The timing of tuberculosis after isoniazid preventive therapy among gold miners in South Africa: a prospective cohort study
por: Hermans, Sabine M., et al.
Publicado: (2016)

Resistance to Mycobacterium tuberculosis infection among highly TB exposed South African gold miners
por: Chihota, Violet N., et al.
Publicado: (2022)

"That is why I stopped the ART": Patients' & providers' perspectives on barriers to and enablers of HIV treatment adherence in a South African workplace programme
por: Dahab, Mison, et al.
Publicado: (2008)

Aortic Arch Thrombosis Associated with Fetal Cytomegalovirus Viremia
por: Yapar Eyi, Elif Gul, et al.
Publicado: (2019)

Predictors of Viremia in Postpartum Women on Antiretroviral Therapy
por: Hoffman, Risa M., et al.
Publicado: (2020)

Cytomegalovirus Viremia in Renal Transplant Recipients After Influenza Vaccination
por: Khatri, Akshay M, et al.
Publicado: (2020)

Cytomegalovirus Viremia after Living and Deceased Donation in Kidney Transplantation
por: Jehn, Ulrich, et al.
Publicado: (2020)

1746. Prevalence and Resistance Patterns of Cytomegalovirus Viremia in Immunocompromised Patients
por: Kim, Edward, et al.
Publicado: (2019)

High Tuberculosis Prevalence in a South African Prison: The Need for Routine Tuberculosis Screening
por: Telisinghe, Lilanganee, et al.
Publicado: (2014)

The Diagnostic Accuracy of Urine Lipoarabinomannan Test for Tuberculosis Screening in a South African Correctional Facility
por: Hanifa, Yasmeen, et al.
Publicado: (2015)

Detection of Adeno-Associated Virus Viremia in Hematopoietic Cell Transplant Recipients
por: Heugel, Judson, et al.
Publicado: (2011)

Third-party cytomegalovirus-specific T cells improved survival in refractory cytomegalovirus viremia after hematopoietic transplant
por: Prockop, Susan E., et al.
Publicado: (2023)

Cytomegalovirus Immunity Assays Predict Viremia but not Replication Within the Lung Allograft
por: Li, Jenny, et al.
Publicado: (2023)

QuantiFERON-Cytomegalovirus Assay for Prediction of Cytomegalovirus Viremia in Kidney Transplant Recipients: Study From High Cytomegalovirus Seroprevalence Country
por: Pongsakornkullachart, Kritsada, et al.
Publicado: (2022)

Cells producing residual viremia during antiretroviral treatment appear to contribute to rebound viremia following interruption of treatment
por: Aamer, Hadega A., et al.
Publicado: (2020)

Persistent HIV-1 Viremia on Antiretroviral Therapy: Measurement and Mechanisms
por: Jacobs, Jana L., et al.
Publicado: (2019)

Outcomes of Cytomegalovirus Viremia Treatment in Critically Ill Patients With COVID-19 Infection
por: Schoninger, Scott, et al.
Publicado: (2022)

Antiretroviral therapy (ART) management of Low-Level Viremia in Taiwan (ALLEVIATE)
por: Cheng, Chien-Yu, et al.
Publicado: (2014)

Reduced adherence to antiretroviral therapy is associated with residual low-level viremia
por: Maggiolo, Franco, et al.
Publicado: (2017)

Factors associated with viremia in people living with HIV on antiretroviral therapy in Guatemala
por: Ortíz, Dean W., et al.
Publicado: (2021)

Hepatitis B viremia in HIV-coinfected individuals under antiretroviral therapy
por: Weissmann, Leonardo, et al.
Publicado: (2019)

Rapid Seeding of the Viral Reservoir Prior to SIV Viremia in Rhesus Monkeys
por: Whitney, James B., et al.
Publicado: (2014)

Cytomegalovirus viremia as a risk factor for mortality in HIV-associated cryptococcal and tuberculous meningitis
por: Skipper, Caleb P., et al.
Publicado: (2022)

The incidence of tuberculosis among hiv-positive individuals with high CD4 counts: implications for policy
por: Kufa, Tendesayi, et al.
Publicado: (2016)

Estimating the yield of tuberculosis from key populations to inform targeted interventions in South Africa: a scoping review
por: Chimoyi, Lucy Andere, et al.
Publicado: (2020)

An ecological study to evaluate the association of Bacillus Calmette-Guerin (BCG) vaccination on cases of SARS-CoV2 infection and mortality from COVID-19
por: Chimoyi, Lucy, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_68vopes38vvs9tj7vrosu60bib